The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,282.50
Bid: 1,285.00
Ask: 1,285.50
Change: -9.50 (-0.74%)
Spread: 0.50 (0.039%)
Open: 1,291.50
High: 1,323.00
Low: 1,274.00
Prev. Close: 1,292.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

19 Mar 2018 11:59

RNS Number : 1550I
Persimmon PLC
19 March 2018
 

19 March 2018

 

Persimmon Plc (the "Company")

 

Annual Report 2017 and Annual General Meeting

 

Following the release of our 2017 final results on 27 February 2018, the Company announces that the following documents are today being made available to shareholders:-

 

1. Annual Report for the year ended 31 December 2017;

2. Notice of Annual General Meeting to be held on 25 April 2018 and Explanatory Circular; and

3. Proxy Form for the 2018 Annual General Meeting.

 

As detailed in the Annual Report, the management team continues to pursue the execution of the Group's new strategy launched in 2012 with great success. Given the strong performance and financial position of the Group, having completed its annual review of the availability of surplus capital, the Board concluded to increase the Capital Return Plan to shareholders. The total value of the Capital Return Plan was increased to £13.00 per share to 2021, more than double the £6.20 per share original commitment made by the Board in 2012. This has been achieved by management whilst at the same time having invested c. £3.2bn in land, opened 1,189 new sales outlets, and increased output by over 70% to deliver over 80,000 new homes to the Group's customers over the last 6 years.

 

In addition, the Company recently announced on 15 March 2018 the appointment of Roger Devlin as Chairman from 1 June 2018. Nigel Mills, Senior Independent Director and Acting Chairman of the Company said "Following a very thorough process, the Board has agreed that Roger is the right candidate to chair Persimmon. I am sure that his wide business experience and his personal qualities will enable him to make a significant contribution to the future of the Group."

 

We believe it to be in the best interests of the Company and its shareholders now to move forwards. The 2017 PSP was supported by 95% of shareholders at last year's AGM and further amendments are being made to 2018 remuneration and to the overall remuneration approach in the future. The Executives have offered reductions in their contractual entitlements, accountability has been shown at Board level and further governance changes have been introduced including, most recently, the appointment of a new Chairman. The business, led by an excellent and committed management team, continues to perform well. Accordingly, we are asking that shareholders support all the resolutions at the forthcoming AGM.

 

Detailed information may be found in the Annual Report 2017. Printed copies of the Annual Report 2017 and Notice of Annual General Meeting 2018 are available on request from the Company Secretary, Persimmon Plc, Persimmon House, Fulford, York, YO19 4FE and are also available to view on our Company website at: persimmonhomes.com/corporate/investors.

 

In accordance with Listing Rule 9.6.1, a copy of each of the above documents has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSBBGDXIUBBGIC
Date   Source Headline
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.